Patents by Inventor Shiu-Hwa Yeh

Shiu-Hwa Yeh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10597378
    Abstract: Disclosed are compounds of formula (I) below or pharmaceutically acceptable salts thereof: in which each of variables R1-R6, L, m, and n is defined herein. Also disclosed are a method for treating an opioid receptor-associated condition with a compound of formula (I) and a pharmaceutical composition containing same.
    Type: Grant
    Filed: September 8, 2017
    Date of Patent: March 24, 2020
    Assignee: National Health Research Institutes
    Inventors: Shau-Hua Ueng, Shiu-Hwa Yeh, Po-Kuan Chao, Chuan Shih
  • Patent number: 10544113
    Abstract: A pharmaceutical composition containing a compound of Formula (I) for treating an opioid receptor-associated condition. Also disclosed is a method for treating an opioid receptor-associated condition using such a compound. Further disclosed are two sets of thiazolidinone compounds of formula (I): (i) compounds each having an enantiomeric excess greater than 90% and (ii) compounds each being substituted with deuterium.
    Type: Grant
    Filed: March 3, 2017
    Date of Patent: January 28, 2020
    Assignees: National Health Research Institute, Regents of the University of Minnesota
    Inventors: Shau-Hua Ueng, Shiu-Hwa Yeh, Shu-Yu Lin, Chuan Shih, Horace Loh
  • Publication number: 20190077786
    Abstract: Disclosed are compounds of formula (I) below or pharmaceutically acceptable salts thereof: in which each of variables R1-R6, L, m, and n is defined herein. Also disclosed are a method for treating an opioid receptor-associated condition with a compound of formula (I) and a pharmaceutical composition containing same.
    Type: Application
    Filed: September 8, 2017
    Publication date: March 14, 2019
    Inventors: Shau-Hua Ueng, Shiu-Hwa Yeh, Po-Kuan Chao, Chuan Shih
  • Patent number: 9827228
    Abstract: Disclosed is an in vitro screening method for identifying an antagonist-to-agonist allosteric modifier of a mu-opioid receptor and an in vivo method for confirming that a test compound is such a modifier of a mu-opioid receptor. Also disclosed is a method for treating an opioid receptor-associated condition using a compound of Formula (I) and a pharmaceutical composition containing the same.
    Type: Grant
    Filed: July 12, 2016
    Date of Patent: November 28, 2017
    Assignees: National Health Research Institutes, Regents of the University of Minnesota
    Inventors: Shau-Hua Ueng, Shiu-Hwa Yeh, Horace Loh, Yu-Sheng Chao
  • Publication number: 20170253569
    Abstract: A pharmaceutical composition containing a compound of Formula (I) for treating an opioid receptor-associated condition. Also disclosed is a method for treating an opioid receptor-associated condition using such a compound. Further disclosed are two sets of thiazolidinone compounds of formula (I): (i) compounds each having an enantiomeric excess greater than 90% and (ii) compounds each being substituted with deuterium.
    Type: Application
    Filed: March 3, 2017
    Publication date: September 7, 2017
    Inventors: Shau-Hua Ueng, Shiu-Hwa Yeh, Shu-Yu Lin, Chuan Shih
  • Publication number: 20170056377
    Abstract: Disclosed is an in vitro screening method for identifying an antagonist-to-agonist allosteric modifier of a mu-opioid receptor and an in vivo method for confirming that a test compound is such a modifier of a mu-opioid receptor. Also disclosed is a method for treating an opioid receptor-associated condition using a compound of Formula (I) and a pharmaceutical composition containing the same.
    Type: Application
    Filed: July 12, 2016
    Publication date: March 2, 2017
    Inventors: Shau-Hua Ueng, Shiu-Hwa Yeh, Horace Loh, Yu-Sheng Chao